Medical and Diagnostic Laboratories
New York, New York
2-10 employees
Founded 2020
About Isabl
Isabl develops comprehensive cancer diagnostic assays by sequencing full tumor DNA, germline DNA, and RNA to support precision-medicine decisions. The company provides whole-genome and transcriptome sequencing tests, bioinformatics platforms, and analytical services to oncologists, hospitals, and clinical laboratories. Its proprietary Isabl GxT platform aims to provide unprecedented clarity into tumor biology, particularly for pediatric and rare solid-tumor patients.
Company Classification
Customer Types
B2B
Business Models
ProductsServices
Product & Service Types
Genomic diagnostic testsBioinformatics data analysis platformsWhole-genome sequencing services
Customers
| Customer | Success Story | Source |
|---|---|---|
| Memorial Sloan Kettering Cancer Center uses Isabl's whole genome and transcriptome sequencing to offer pediatric cancer patients comprehensive genomic profiling for potential targeted therapies. |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos